Genocea Biosciences, Inc. Commences Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil falls 4% as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
Genocea Biosciences (GNCA) Falls on Plans to Offer Common Stock
July 29, 2015 5:53 PM EDTGenocea Biosciences (NASDAQ: GNCA) is trading down 8% after-hours after the company announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of this proposed offering, Genocea intends to grant the underwriters a 30-day... More
